Takeda Licenses Rights to

... Read more

ImmunoGen’s Mirvetuximab Soravtansine (IMGN853) Demonstrates Notable Single Agent Activity for Patients with Platinum-Resistant

... Read more

Jazz Pharmaceuticals and ImmunoGen, Inc. Announce a Strategic Collaboration and

... Read more

U.S. Food and Drug

... Read more

Immunomedics Enters into Exclusive Global Licensing Agreement with Seattle

... Read more

Immunomedics Delivers Business Updates, Announces Private Placement Offering

... Read more

Impax To Acquire Tower Holdings, Inc. And Lineage Therapeutics Inc.

... Read more

Imprimis Pharmaceuticals Announces New Economic Study

... Read more

IMRIS neurosurgical HFD

... Read more

INC Research Reports

... Read more